Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 2 |
2015 | 1 |
2016 | 1 |
2017 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Metastatic melanoma moves on: translational science in the era of personalized medicine.
Cancer Metastasis Rev. 2017 Mar;36(1):7-21. doi: 10.1007/s10555-017-9658-0.
Cancer Metastasis Rev. 2017.
PMID: 28321632
Free article.
Review.
Melanoma immunotherapy: historical precedents, recent successes and future prospects.
Raaijmakers MI, Rozati S, Goldinger SM, Widmer DS, Dummer R, Levesque MP.
Raaijmakers MI, et al.
Immunotherapy. 2013 Feb;5(2):169-82. doi: 10.2217/imt.12.162.
Immunotherapy. 2013.
PMID: 23413908
Review.
Item in Clipboard
Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma.
Hogan SA, Courtier A, Cheng PF, Jaberg-Bentele NF, Goldinger SM, Manuel M, Perez S, Plantier N, Mouret JF, Nguyen-Kim TDL, Raaijmakers MIG, Kvistborg P, Pasqual N, Haanen JBAG, Dummer R, Levesque MP.
Hogan SA, et al. Among authors: raaijmakers mig.
Cancer Immunol Res. 2019 Jan;7(1):77-85. doi: 10.1158/2326-6066.CIR-18-0136. Epub 2018 Nov 13.
Cancer Immunol Res. 2019.
PMID: 30425105
Free article.
Clinical Trial.
Item in Clipboard
A new live-cell biobank workflow efficiently recovers heterogeneous melanoma cells from native biopsies.
Raaijmakers MI, Widmer DS, Maudrich M, Koch T, Langer A, Flace A, Schnyder C, Dummer R, Levesque MP.
Raaijmakers MI, et al.
Exp Dermatol. 2015 May;24(5):377-80. doi: 10.1111/exd.12683.
Exp Dermatol. 2015.
PMID: 25739758
Item in Clipboard
The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype.
Vandamme N, Denecker G, Bruneel K, Blancke G, Akay Ö, Taminau J, De Coninck J, De Smedt E, Skrypek N, Van Loocke W, Wouters J, Nittner D, Köhler C, Darling DS, Cheng PF, Raaijmakers MIG, Levesque MP, Mallya UG, Rafferty M, Balint B, Gallagher WM, Brochez L, Huylebroeck D, Haigh JJ, Andries V, Rambow F, Van Vlierberghe P, Goossens S, van den Oord JJ, Marine JC, Berx G.
Vandamme N, et al. Among authors: raaijmakers mig.
Cancer Res. 2020 Jul 15;80(14):2983-2995. doi: 10.1158/0008-5472.CAN-19-2373. Epub 2020 Jun 5.
Cancer Res. 2020.
PMID: 32503808
Item in Clipboard
Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching.
Widmer DS, Hoek KS, Cheng PF, Eichhoff OM, Biedermann T, Raaijmakers MIG, Hemmi S, Dummer R, Levesque MP.
Widmer DS, et al. Among authors: raaijmakers mig.
J Invest Dermatol. 2013 Oct;133(10):2436-2443. doi: 10.1038/jid.2013.115. Epub 2013 Mar 8.
J Invest Dermatol. 2013.
PMID: 23474946
Free article.
Item in Clipboard
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
Raaijmakers MI, Widmer DS, Narechania A, Eichhoff O, Freiberger SN, Wenzina J, Cheng PF, Mihic-Probst D, Desalle R, Dummer R, Levesque MP.
Raaijmakers MI, et al.
Oncotarget. 2016 Nov 22;7(47):77163-77174. doi: 10.18632/oncotarget.12848.
Oncotarget. 2016.
PMID: 27791198
Free PMC article.
Item in Clipboard
Cite
Cite